# Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors

> **NCT00390000** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** vatalanib
- **DRUG:** pemetrexed disodium
- **OTHER:** pharmacological study
- **PROCEDURE:** ultrasound imaging

## Key facts

- **NCT ID:** NCT00390000
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-25
- **Primary completion:** 2016-08-04
- **Final completion:** 2016-08-04
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2019-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00390000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00390000, "Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00390000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*